NCCN Clinical Practice Guidelines in Oncology for Kidney Cancer

被引：90

作者：

Motzer, Robert J. ^{[1
]}

Agarwal, Neeraj ^{[2
]}

Beard, Clair

Bhayani, Sam ^{[3
,4
]}

Bolger, Graeme B. ^{[5
]}

Carducci, Michael A.

Chang, Sam S.

Choueiri, Toni K.

Hancock, Steven L.

Hudes, Gary R.

Jonasch, Eric ^{[6
]}

Josephson, David

Kuzel, Timothy M. ^{[7
]}

Levine, Ellis G. ^{[8
]}

Lin, Daniel W. ^{[9
]}

Margolin, Kim A. ^{[10
]}

Michaelson, M. Dror ^{[11
]}

Olencki, Thomas ^{[12
]}

Pill, Roberto ^{[8
]}

Ratliff, Thomas W. ^{[13
]}

Redman, Bruce G. ^{[14
]}

Robertson, Cary N.

Ryan, Charles J. ^{[15
]}

Sheinfeld, Joel ^{[1
]}

Spiess, Philippe E. ^{[16
]}

Wang, Jue

Wilder, Richard B. ^{[16
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, New York, NY USA

[2] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[3] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO USA

[4] Washington Univ, Sch Med, St Louis, MO 63130 USA

[5] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA

[6] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[7] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[8] Roswell Pk Canc Inst, Buffalo, NY USA

[9] Univ Washington, Seattle, WA 98195 USA

[10] Fred Hutchinson Canc Res Ctr, Seattle, WA USA

[11] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA

[12] Ohio State Univ, Ctr Comprehens Canc, James Canc Hosp, Columbus, OH 43210 USA

[13] Univ Tennessee, Inst Canc, St Jude Childrens Res Hosp, Knoxville, TN 37996 USA

[14] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA

[15] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[16] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2011年 / 9卷 / 09期

关键词：

NCCN Clinical Practice Guidelines; NCCN Guidelines; renal cell carcinoma; clear cell tumors; kidney disease; nephrectomy; RENAL-CELL CARCINOMA; NEPHRON-SPARING SURGERY; GROWTH-FACTOR RECEPTOR; KINASE INHIBITORS SORAFENIB; DAYS ON/7 DAYS; INTERFERON-ALPHA; RADICAL NEPHRECTOMY; PHASE-III; DOUBLE-BLIND; RAF KINASE;

D O I：

10.6004/jnccn.2011.0082

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：960 / 977

页数：18

共 84 条

[1]

[Anonymous], J CLIN ONCOL S1

[2]

[Anonymous], MED ONCOL IN PRESS

[3]

[Anonymous], ASCO GEN CANC S 2009

[4]

[Anonymous], NEW ENGL J MED

[5]

[Anonymous], J UROL

[6]

[Anonymous], J CLIN ONCOL S1

[7]

[Anonymous], P AM SOC CLIN ONCOL

[8]

Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours [J].

Awada, A ;

Hendlisz, A ;

Gil, T ;

Bartholomeus, S ;

Mano, M ;

de Valeriola, D ;

Strumberg, D ;

Brendel, E ;

Haase, CG ;

Schwartz, B ;

Piccart, M .

BRITISH JOURNAL OF CANCER, 2005, 92 (10) :1855-1861

[9]

Radical Nephrectomy with and without Lymph-Node Dissection: Final Results of European Organization for Research and Treatment of Cancer (EORTC) Randomized Phase 3 Trial 30881 [J].

Blom, Jan H. M. ;

van Poppel, Hein ;

Marechal, Jean M. ;

Jacqmin, Didier ;

Schroder, Fritz H. ;

de Prijck, Linda ;

Sylvester, Richard .

EUROPEAN UROLOGY, 2009, 55 (01) :28-34

[10]

A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma [J].

Blute, ML ;

Leibovich, BC ;

Cheville, JC ;

Lohse, CM ;

Zincke, H .

JOURNAL OF UROLOGY, 2004, 172 (02) :465-469

← 1 2 3 4 5 6 7 8 9 →